How Fertility Declines With Age: What the Data Actually Shows
Fertility declines with age in both women and men, but the timeline and mechanisms differ. Understanding the actual data helps individuals make informed decisions about family planning.
Why Age Matters for Fertility
Fertility is fundamentally a biological process constrained by time — for women more acutely, for men more gradually. Understanding the actual demographic and clinical data on age-related fertility decline helps individuals and couples make more informed decisions about when to start a family, when to seek evaluation, and what options are available when conception proves difficult.
The narrative around female fertility is sometimes more alarming than the data fully supports for women in their early 30s, while the challenges facing women in their late 30s and 40s are real and clinically meaningful. Separating statistical trends from individual variation requires looking at what the research actually measures.
Female Fertility: The Biology of the Ovarian Reserve
Women are born with all the eggs they will ever have — approximately one to two million at birth, declining to 300,000 to 500,000 by puberty. Unlike men, who produce new sperm continuously, women's egg supply only decreases. By menopause, the reserve is essentially exhausted. The biological term for this supply is the ovarian reserve.
But quantity is only part of the picture. Egg quality — specifically the accuracy of chromosomal segregation during meiosis — also declines with age. Errors in chromosomal separation produce aneuploid embryos, which are the primary cause of both miscarriage and failed implantation. At age 30, roughly 20 to 25 percent of eggs are chromosomally abnormal. By 40, estimates range from 50 to 80 percent. This is why age affects not only the chance of conception but also the rate of miscarriage and the likelihood of conditions like Down syndrome.
What the Population Data Shows
Large prospective studies tracking natural conception rates by age provide the clearest picture. A widely cited study by David Dunson and colleagues analyzing fertile couples attempting conception found that the proportion of women conceiving within 12 months was:
- Approximately 86 percent for women aged 27 to 34.
- Approximately 82 percent for women aged 35 to 39.
- Approximately 79 percent for women aged 40 to 45 in the first six months of trying.
These figures are more optimistic than many women expect — the difference between early 30s and late 30s is real but less dramatic than popular culture suggests. The decline becomes more significant and clinically relevant after age 37 to 38. Another widely discussed source — historical demographic data from pre-contraception European populations — is frequently cited to suggest sharper declines, but these datasets reflect populations with no access to modern healthcare or nutrition and may overstate the contemporary decline.
The Miscarriage and IVF Perspective
Even when conception occurs, age-related chromosomal abnormalities mean older pregnancies are more likely to end in miscarriage. The miscarriage rate for women under 30 is approximately 10 to 12 percent. By age 40, it rises to approximately 34 to 40 percent. By 45, rates exceed 50 percent. This is almost entirely attributable to aneuploid embryos, not maternal uterine or health factors.
IVF success rates show the age-fertility relationship clearly, since they are tracked by regulatory bodies and published annually. The CDC's ART (Assisted Reproductive Technology) report shows live birth rates per egg retrieval cycle:
- Under 35: approximately 45 to 52 percent per cycle.
- Ages 35 to 37: approximately 32 to 40 percent.
- Ages 38 to 40: approximately 20 to 26 percent.
- Ages 41 to 42: approximately 10 to 13 percent.
- Over 43: approximately 3 to 5 percent with own eggs.
Using donor eggs from younger women eliminates the age-related decline in IVF success rates entirely, demonstrating that the decline is driven by egg quality, not uterine receptivity.
Male Fertility and Age
Male fertility also declines with age, though more gradually and with less dramatic clinical impact than female age-related decline. Sperm production continues throughout life, but sperm quality changes: motility and morphology decline modestly with age, and the frequency of de novo mutations in sperm DNA increases. Advanced paternal age (generally defined as 45 and older) is associated with increased risk of certain conditions in offspring including autism spectrum disorder, schizophrenia, and achondroplasia, though the absolute risk remains low.
Men over 40 partnered with women under 35 take approximately twice as long to conceive as younger men in the same situation. The male contribution to fertility decline is real but secondary to female age effects in most clinical contexts.
Fertility Preservation: Egg and Embryo Freezing
Elective egg freezing (oocyte cryopreservation) allows women to freeze eggs retrieved at a younger age for potential future use. Success rates using frozen eggs improve with younger age at freezing: eggs frozen before 35 produce meaningfully better outcomes than eggs frozen after 37 to 38. Most fertility specialists recommend egg freezing if desired before age 37 and ideally before 35.
Embryo freezing (after fertilization with partner or donor sperm) has slightly higher survival rates per frozen unit than egg freezing alone. Both options come with significant financial cost ($10,000 to $20,000 per retrieval cycle, plus storage fees) and no guarantee of success.
When to Seek Fertility Evaluation
The standard medical recommendation is to seek evaluation after 12 months of regular unprotected intercourse under age 35, and after 6 months at or above age 35. For women over 40, earlier evaluation — even before trying — is reasonable given the compressed timeline. Evaluation for both partners should happen simultaneously, as male factor infertility contributes to approximately 40 to 50 percent of cases.
Early evaluation and, when indicated, early treatment maximize the range of options available. Waiting longer than recommended timelines before seeking help narrows those options progressively.
Related Articles
womens health
Autoimmune Diseases in Women: Why Women Are Disproportionately Affected
A detailed exploration of autoimmune diseases and their disproportionate impact on women, covering the most common conditions, the biological and hormonal reasons for this disparity, and approaches to diagnosis and management.
10 min read
womens health
Hormone Replacement Therapy for Menopause: Benefits, Risks, and Options
HRT remains the most effective treatment for menopause symptoms. Learn what the latest evidence says about benefits, risks, and which women are good candidates.
9 min read
womens health
How Breast Cancer Screening Methods Work: Mammography and Beyond
Compare breast cancer screening methods including mammography, ultrasound, MRI, and emerging technologies, plus current guidelines by risk level and age group.
9 min read
womens health
How Hormonal Birth Control Affects the Body Beyond Contraception
Hormonal birth control does far more than prevent pregnancy — it reshapes hormone cycles, affects mood, bone density, and even libido. Here is what the research actually shows.
9 min read